Cellular senescence in the pathogenesis of ovarian dysfunction
1Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The Journal of Obstetrics and Gynaecology Research
|February 27, 2024
Summary
Cellular senescence, a state of cell aging, negatively impacts ovarian function and oocyte health. Targeting senescent cells offers a promising new strategy for reproductive medicine and treating ovarian pathologies like PCOS.
Area of Science:
- Reproductive Biology
- Cellular Biology
- Gerontology
Background:
- The ovarian microenvironment is vital for reproductive health, regulated by intra-ovarian factors and gonadotropins.
- Cellular senescence, characterized by cell-cycle arrest and a senescence-associated secretory phenotype (SASP), contributes to aging and disease.
- Accumulated senescent cells create detrimental tissue environments, impacting various organs.
Purpose of the Study:
- To review the role of cellular senescence in ovarian pathologies and reproductive contexts.
- To explore cellular senescence as a potential therapeutic target in reproductive medicine.
Main Methods:
- Literature review summarizing current knowledge on cellular senescence in ovarian function.
- Analysis of cellular senescence's involvement in primary ovarian insufficiency, PCOS, aging, endometriosis, stress, and obesity.
- Discussion of senomorphic and senolytic strategies for targeting cellular senescence.
Main Results:
- Cellular senescence impairs follicular and oocyte health in conditions like primary ovarian insufficiency.
- Senescence contributes to the pathogenesis of polycystic ovary syndrome (PCOS).
- Senescence is observed during ovarian reserve decline linked to aging, endometriosis, stress, and obesity, though causality is under investigation.
Conclusions:
- Cellular senescence plays a significant role in ovarian pathologies and age-related decline.
- Targeting senescent cells via senomorphic or senolytic therapies presents a novel therapeutic avenue for reproductive disorders.
- Further research into senescence mechanisms in ovarian conditions could revolutionize reproductive medicine.
Related Concept Videos
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Aging
51
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
51
Menopause
158
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
158
Folliculogenesis
765
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
765
Hormonal Control of the Ovarian Cycle
496
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
496


